PetMed Express (NASDAQ: PETS), operating as PetMeds and parent company of PetCareRx, announced it will be unable to file its Form 10-K for FY 2025 within the extension period ending July 1, 2025. The delay is due to an ongoing investigation initiated by the Audit Committee following anonymous whistleblower reports.
The whistleblower complaints concern three main issues: revenue recognition timing for certain autoship orders in Q4 2025 that led to customer complaints, a $50 coupon promotion's impact on new customer KPIs, and concerns about the company's culture and control environment. The Audit Committee has engaged external legal counsel and advisors to investigate these matters.
Despite the ongoing investigation, PetMed Express states that based on current evidence, they do not expect the investigation to materially impact their previously announced preliminary Q4 and FY 2025 financial results or previously filed financial statements.
[ "Company does not expect material impact on previously announced financial results", "External legal counsel and advisors engaged for thorough investigation", "Company has established whistleblower reporting system in place" ]
PetMed's delayed 10-K filing amid whistleblower allegations raises governance concerns despite management downplaying financial impact.
PetMed Express has announced it will miss the extended July 1 deadline for filing its annual Form 10-K report, a concerning development for investors. The delay stems from...
PETALING JAYA: A man who allegedly spread false claims about the death of Zara Qairina Mahathir has been arrested. Bukit Aman Criminal Investigation Department director Comm Datuk M. Kumar said th...